Lee Danner & Bass Inc. Makes New Investment in Danaher Co. (NYSE:DHR)

Lee Danner & Bass Inc. purchased a new stake in shares of Danaher Co. (NYSE:DHR) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 7,998 shares of the conglomerate’s stock, valued at approximately $1,998,000.

A number of other institutional investors also recently bought and sold shares of the company. Tsfg LLC boosted its holdings in shares of Danaher by 733.3% in the first quarter. Tsfg LLC now owns 100 shares of the conglomerate’s stock worth $25,000 after buying an additional 88 shares during the last quarter. CarsonAllaria Wealth Management Ltd. bought a new stake in shares of Danaher during the 2nd quarter valued at $25,000. Cape Investment Advisory Inc. purchased a new stake in shares of Danaher in the 4th quarter worth $25,000. Redmont Wealth Advisors LLC bought a new position in Danaher in the 1st quarter worth $30,000. Finally, Richardson Financial Services Inc. bought a new stake in Danaher during the fourth quarter valued at about $42,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE:DHR traded up $2.29 during mid-day trading on Friday, reaching $269.31. The stock had a trading volume of 4,595,672 shares, compared to its average volume of 2,803,002. The company has a market cap of $199.47 billion, a P/E ratio of 45.65, a price-to-earnings-growth ratio of 4.62 and a beta of 0.83. The business’s 50 day moving average price is $259.76 and its 200 day moving average price is $254.94. The company has a current ratio of 1.43, a quick ratio of 1.04 and a debt-to-equity ratio of 0.33. Danaher Co. has a 1 year low of $182.09 and a 1 year high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, July 23rd. The conglomerate reported $1.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.57 by $0.15. Danaher had a return on equity of 11.06% and a net margin of 16.94%. The business had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same period in the prior year, the firm earned $2.05 EPS. The company’s revenue for the quarter was down 2.9% on a year-over-year basis. Research analysts expect that Danaher Co. will post 7.59 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. TD Cowen raised their price objective on Danaher from $290.00 to $310.00 and gave the stock a “buy” rating in a research note on Wednesday, July 24th. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a research note on Tuesday, June 25th. Bank of America upped their price target on shares of Danaher from $270.00 to $275.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 24th. Leerink Partners raised their price objective on shares of Danaher from $275.00 to $280.00 and gave the company an “outperform” rating in a research report on Wednesday, July 24th. Finally, Jefferies Financial Group initiated coverage on shares of Danaher in a research note on Monday, June 3rd. They set a “buy” rating and a $295.00 target price on the stock. Seven investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $278.94.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 9,600 shares of the business’s stock in a transaction dated Thursday, July 25th. The shares were sold at an average price of $275.16, for a total value of $2,641,536.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $5,566,486.80. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, SVP Brian W. Ellis sold 9,600 shares of Danaher stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $275.16, for a total value of $2,641,536.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $5,566,486.80. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now directly owns 4,212 shares in the company, valued at approximately $1,130,374.44. The disclosure for this sale can be found here. Insiders sold 39,659 shares of company stock worth $11,042,433 over the last 90 days. 11.10% of the stock is owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.